Health behaviors of early-stage non-small cell lung cancer survivors

被引:23
|
作者
Krebs, Paul [1 ,2 ]
Coups, Elliot J. [3 ,4 ]
Feinstein, Marc B. [5 ]
Burkhalter, Jack E. [2 ]
Steingart, Richard M. [5 ]
Logue, Amy [6 ]
Park, Bernard J. [7 ]
Ostroff, Jamie S. [2 ]
机构
[1] NYU, Sch Med, Div Gen Internal Med, New York, NY 10010 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA
[3] UMDNJ Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Med, New Brunswick, NJ USA
[4] UMDNJ Sch Publ Hlth, Dept Hlth Educ & Behav Sci, New Brunswick, NJ USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[7] Hackensack Univ, Med Ctr, Dept Thorac Surg, New York, NY USA
关键词
Health behavior; Cancer screening; Survivorship; Lung cancer; QUALITY-OF-LIFE; LONG-TERM SURVIVORS; 2ND PRIMARY CANCERS; UNITED-STATES; RISK; SMOKING; ASSOCIATIONS; CONSUMPTION; DIAGNOSIS; EXERCISE;
D O I
10.1007/s11764-011-0191-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Lung cancer survivors are at risk for cancer recurrence and other chronic illnesses related predominantly to prior tobacco use and older age. Optimal quality of post-treatment care requires greater knowledge of survivors' adherence to behavioral health recommendations. This study reports the rates of smoking, physical activity, alcohol use, cancer screenings, and routine primary care visits in non-small cell lung cancer (NSCLC) survivors. Methods Stage IA and IB NSCLC survivors (N = 183, mean age = 69.0 years) with no evidence of disease 1-6 years post-treatment completed standard survey items regarding health and cancer screening behaviors. Results Most survivors (83.5%) had a history of smoking, but 64.8% quit prior to diagnosis and only 5.5% continued to smoke. Alcohol intake recommendations were exceeded by 5.4% and 17.3% of men and women, respectively. In a typical week, 23.1% met physical activity guidelines. Regarding cancer screenings, 89.3% were adherent to colorectal cancer screening guidelines. Among women, 72.0% had a mammogram within the previous year and 81.5% had a pap test in the previous 3 years; among men, 86.7% had a prostate-specific antigen test in the previous year. Almost all (97.3%) had seen a primary care provider in the past year. Discussions/conclusions The majority of lung cancer survivors were adherent to health promotion recommendations, but few engaged in the recommended level of physical activity. Implications for cancer survivors Physical and pulmonary rehabilitation interventions may help lung cancer survivors maintain sufficient levels of physical activity, which can have numerous benefits for older adults.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 50 条
  • [21] Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
    Shin, Jacob Y.
    Yoon, Ja Kyoung
    Marwaha, Gaurav
    LUNG, 2018, 196 (03) : 351 - 358
  • [22] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
    Shukla, Nikhil
    Hanna, Nasser
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
  • [23] Disparities in surgical resection of early-stage non-small cell lung cancer
    Jazieh, AR
    Kyasa, MJ
    Sethuraman, G
    Howington, J
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (06): : 1173 - 1176
  • [24] EARLY-STAGE NON-SMALL CELL LUNG CANCER STRATIFYING RECURRENCE RISK
    Saito, T.
    Kono, Y.
    Ueno, Y.
    Maru, N.
    Utsumi, T.
    Matsui, H.
    Taniguchi, Y.
    Hino, H.
    Tsuta, K.
    Honda, O.
    Murakawa, T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S559 - S560
  • [25] Waiting times in early-stage non-small cell lung cancer (NSCLC)
    Saint-Jacques, Nathalie
    Rayson, Daniel
    Al-Fayea, Turki
    Virik, Kiran
    Morzycki, Wojciech
    Younis, Tallal
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 865 - 870
  • [26] Is Brain MRI Unnecessary for Early-Stage Non-Small Cell Lung Cancer?
    Bizzi, Alberto
    Pascuzzo, Riccardo
    RADIOLOGY, 2022, 303 (03) : 644 - 645
  • [27] Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer
    Inamura, Kentaro
    JAMA ONCOLOGY, 2021, 7 (04) : 637 - 638
  • [28] Docetaxel in neoadjuvant therapy of early-stage non-small cell lung cancer
    Betticher, DC
    ONKOLOGIE, 2003, 26 : 33 - 36
  • [29] Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017
    Donington, Jessica S.
    Kim, Young Tae
    Tong, Betty
    Moreira, Andre L.
    Bessich, Jamie
    Weiss, Kathleen D.
    Colson, Yolonda L.
    Wigle, Dennis
    Osarogiagbon, Raymond U.
    Zweig, Jeffrey
    Wakelee, Heather
    Blasberg, Justin
    Daly, Megan
    Backhus, Leah
    Van Schil, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 767 - 778
  • [30] Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer
    Streit, Arthur
    Lampridis, Savvas
    Seitlinger, Joseph
    Renaud, Stephane
    Routledge, Tom
    Bille, Andrea
    CURRENT ONCOLOGY REPORTS, 2024, 26 (01) : 55 - 64